Compugen Names Lead Therapeutic Candidate For CGEN-15029 Immuno-Oncology Program IND filing For COM701 Anticipated in 2017

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.